Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
The adeno-associated viruses (AAVs) can package and deliver foreign DNA into cells for corrective gene delivery applications. The AAV serotypes have distinct cell binding, transduction, and antigenic characteristics that have been shown to be dictated by the capsid viral protein (VP) sequence. To understand the contribution of capsid structure to these properties, we have determined the crystal structure of AAV serotype 4 (AAV4), one of the most diverse serotypes with respect to capsid protein sequence and antigenic reactivity. Structural comparison of AAV4 to AAV2 shows conservation of the core β strands (βB to βI) and helical (αA) secondary structure elements, which also exist in all other known parvovirus structures. However, surface loop variations (I to IX), some containing compensating structural insertions and deletions in adjacent regions, result in local topological differences on the capsid surface. These include AAV4 having a deeper twofold depression, wider and rounder protrusions surrounding the threefold axes, and a different topology at the top of the fivefold channel from that of AAV2. Also, the previously observed “valleys” between the threefold protrusions, containing AAV2's heparin binding residues, are narrower in AAV4. The observed differences in loop topologies at subunit interfaces are consistent with the inability of AAV2 and AAV4 VPs to combine for mosaic capsid formation in efforts to engineer novel tropisms. Significantly, all of the surface loop variations are associated with amino acids reported to affect receptor recognition, transduction, and anticapsid antibody reactivity for AAV2. This observation suggests that these capsid regions may also play similar roles in the other AAV serotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The AAV capsids have nine variable regions surrounded by conserved regions where the variable regions form loops and clusters on the exterior of the capsid.18–19”
From Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism (2016) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These protrusions are formed from interdigitating loops from two VPs and have the most extensive VP–VP interactions [23,24].”
From Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses (2017) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“This region has the least number of VP–VP interface interactions and represents the thinnest region of the virus capsid shell [23,24].”
From Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses (2017) · cites this paper as [23]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This includes the recombinant AAV vector rAAV2.7m8 (Dalkara et al., 2013), which is derived from the natural serotype AAV2 and was isolated by directed evolution when screening for increased transduction of the mouse retina following intravitreal (IVT) administration.”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Govindasamy et al., 2006
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828 · cited 4×
“This figure was generated using the Chimera program (54).”
MethodInfluentialThe PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320 · cited 1×
“The secondary structure elements were assigned using the DSSP program (30).”
MethodJones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 2×
“space electron density averaging, and rebuilding (6, 29).”
BackgroundMethodThe interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850 · cited 1×
“This algorithm utilizes the method of buried surface calculation reported by Lee and Richards ( 42 ), assuming a probe radius of 1.4 A.”
MethodInfluentialAQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502 · cited 1×
“angles using the PROCHECK program (41) (Table 1).”
MethodNicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240 · cited 5×
“Panels A and B were generated using the BOBSCRIPT program (15) and rendered with the RASTER3d program (48); panels C and D were generated using the GRASP program (51).”
MethodInfluentialFree R value: a novel statistical quantity for assessing the accuracy of crystal structures
Brünger, A. T. (1992) · Nature · doi:10.1038/355472a0 · Cited by 3,873 · cited 1×
“A test data set of 5% was partitioned for monitoring of the refinement process ( 5 ).”
MethodKrissinel, E., & Henrick, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904026460 · Cited by 3,760
Research works printed but not linked: 2
- Kleywegt, G. J., and T. A. Jones. 1994. Halloween…masks and bones, p. 59-66. In S. Bailey, R. Hubbard, and D. Waller (ed.), From first map to final model. SERC Daresbury Laboratory, Chilton, United Kingdom.
- Muzyczka, N., and K. I. Berns. 2001. Parvoviridae: the viruses and their replication, p. 2327-2360. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, New York, N.Y.
Cited by
Items 101–200 of 211
Emmanuel, S. N., Smith, J. K., Hsi, J., Tseng, Y.-S., Kaplan, M., Mietzsch, M., Chipman, P. R., Asokan, A., McKenna, R., & Agbandje‐McKenna, M. (2021) · Journal of Virology · doi:10.1128/jvi.01251-21 · Cited by 36
“or more amino acids where the Ca positions are greater than 1 Å apart when the VP structures of AAV serotypes are superposed (32).”
BackgroundSelf-citationHo, M. L., Adler, B. A., Torre, M. L., Silberg, J. J., & Suh, J. (2013) · ACS Synthetic Biology · doi:10.1021/sb400076r · Cited by 36
Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies
Ramamurthy, R. M., Atala, A., Porada, C. D., & Almeida-Porada, G. D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011143 · Cited by 36
Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2
Bennett, A., Keravala, A., Makal, V., Kurian, J., Belbellaa, B., Aeran, R., Tseng, Y.-S., Sousa, D., Spear, J., Gasmi, M., et al. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2019.107433 · Cited by 33
“Several AAV structures have been reported to contain nucleotide density in the capsid interior, referred to as the DNA binding pocket (Govindasamy et al., 2006; Halder et al., 2015; Lerch et al., 2010; Mikals et al., 2014; Nam et al., 2007; Ng et al., 2010).”
BackgroundMethodInfluentialSelf-citationEmmanuel, S. N., Mietzsch, M., Tseng, Y.-S., Smith, J. K., & Agbandje‐McKenna, M. (2021) · Viral Immunology · doi:10.1089/vim.2020.0022 · Cited by 33
“The differences at the apexes of these loops are termed variable regions (VRs) defined as two or more amino acids with Ca positions greater than 1Å apart when the VP structures of the different AAV serotypes are superposed (46).”
BackgroundSelf-citationVliet, K. V., Mohiuddin, Y., McClung, S. H., Blouin, V., Rolling, F., Moullier, P., Agbandje‐McKenna, M., & Snyder, R. O. (2009) · Journal of Virological Methods · doi:10.1016/j.jviromet.2009.03.020 · Cited by 36
Self-citationDevelopment of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity
Pei, X., Shao, W., Xing, A., Askew, C., Chen, X., Cui, C., Abajas, Y. L., Gerber, D. A., Merricks, E. P., Nichols, T. C., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.003 · Cited by 35
“This domain is included in variable region (VR)I of the AAV virion, and it has been implicated that VRI is involved in AAV transduction and Nab recognition.(29) The results from this study support that VRI on the AAV8 capsid plays a role in high human hepatocyte transduction and Nab recognition, while genetic modifica…”
ResultKok, C., Tsurusaki, S., Cabanes‐Creus, M., Igoor, S., Rao, R., Skelton, R. J. P., Liao, S. H. Y., Ginn, S. L., Knight, M., Scott, S., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.08.010 · Cited by 32
“However, the VRs (I-IX), loops between the b strands that form the capsid surface are highly diverse and have a direct effect on the tropism of AAV variants.(30) Among the five AAV variants studied, rAAV.”
BackgroundSelf-citationAtomic structure of a rationally engineered gene delivery vector, AAV2. 5
Burg, M., Rosebrough, C., Drouin, L. M., Bennett, A., Mietzsch, M., Chipman, P., McKenna, R., Sousa, D., Potter, M., Byrne, B., et al. (2018) · Journal of Structural Biology · doi:10.1016/j.jsb.2018.05.004 · Cited by 30
Self-citationSilveria, M., Large, E. E., Zane, G. M., White, T., & Chapman, M. S. (2020) · Viruses · doi:10.3390/v12111326 · Cited by 32
“PKD1 binds to AAV5 near the 3-fold symmetry axis spike, primarily to two of the variable regions (VR) in the AAV sequence that have previously been highlighted [29], namely VR-VII and a segment containing VR-IX.”
BackgroundMitchell, M., Nam, H.-J., Carter, A., McCall, A., Rence, C., Bennett, A., Gurda, B., McKenna, R., Porter, M., Sakai, Y., et al. (2009) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309109021460 · Cited by 29
“…by X-ray crystallography and cryo-electron microscopy and image reconstruction (Xie et al., 2002; Walters et al., 2004; Padron et al., 2005; Govindasamy et al., 2006; Nam et al., 2007) and the crystallization of several others (AAV1, AAV3, AAV5, AAV6 and AAV7) have been reported (DiMattia…”
BackgroundSelf-citationMays, L. E., Wang, L., Tenney, R., Bell, P., Nam, H.-J., Lin, J., Gurda, B., Van Vliet, K., Mikals, K., Agbandje-McKenna, M., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00596-13 · Cited by 27
Self-citationRecombinant AAV-directed gene therapy for type I glycogen storage diseases
Chou, J. Y., & Mansfield, B. C. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.578067 · Cited by 27
“In the last decade, 11 AAV serotypes and over 120 capsid variants have been categorized into six different phylogenetic clades [27-35] and the crystal structures of several AAV serotypes have been solved [36-40].”
BackgroundAncestral Library Identifies Conserved Reprogrammable Liver Motif on AAV Capsid
Zinn, E. M., Unzu, C., Schmit, P. F., Turunen, H., Zabaleta, N., Sanmiguel, J. C., Fieldsend, A., Bhatt, U., Diop, C. T., Merkel, E., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100803 · Cited by 30
Horowitz, E. D., Finn, M. G., & Asokan, A. (2012) · ACS Chemical Biology · doi:10.1021/cb3000265 · Cited by 31
“However, it is well known that the icosahedral two-fold constitutes the weakest interface in the AAV capsid (17, 18).”
BackgroundInfluentialAAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
Marino, M., & Holt, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.870799 · Cited by 22
Current AAV-mediated gene therapy in sensorineural hearing loss
Qi, J., Fu, X., Zhang, L., Tan, F., Li, N., Sun, Q., Hu, X., He, Z., Xia, M., & Chai, R. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.08.015 · Cited by 26
“Each VP subunit contains nine variable regions on the surface of the capsid that determine the cell targeting specificity and the intracellular transport ability of AAV and that are the targets of AAV recognition by corresponding neutralizing antibodies in vivo [ 44 , 45 ].”
Conformational Changes in Adeno-Associated Virus Type 1 Induced by Genome Packaging
Gerlach, B., Kleinschmidt, J. A., & Böttcher, B. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.062 · Cited by 26
Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy
Liu, Y., Siriwon, N., Rohrs, J. A., & Wang, P. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150531171653 · Cited by 26
Tenney, R. M., Bell, C. L., & Wilson, J. M. (2014) · Virology · doi:10.1016/j.virol.2014.02.017 · Cited by 24
Quesada, O., Gurda, B., Govindasamy, L., McKenna, R., Kohlbrenner, E., Aslanidi, G., Zolotukhin, S., Muzyczka, N., & Agbandje-McKenna, M. (2007) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309107060289 · Cited by 20
Self-citationMietzsch, M., Hull, J. A., Makal, V., Ybargollin, A. J., Yu, J. C., McKissock, K., Bennett, A. D., Pénzes, J. J., Lins, B., Yu, Q., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00335-22 · Cited by 19
“defined as variable regions (VRs) (17).”
Self-citationStructural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants
Bennett, A. D., Gargas, J., Kansol, A., Lewis, J., Hsi, J., Hull, J. A., Mietzsch, M., Tartaglia, L. J., Muzyczka, N., Bhattacharya, N., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01772-22 · Cited by 21
“structure between the AAV serotypes that are defined as variable regions (VR I-IX), based on the two structurally diverse serotypes, AAV2 and AAV4 (28).”
BackgroundInfluentialSelf-citationNotarte, K. I., Catahay, J. A., Macasaet, R., Liu, J., Velasco, J. V., Peligro, P. J., Vallo, J., Goldrich, N., Lahoti, L., Zhou, J., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29305 · Cited by 21
“Some studies recommend repeating these tests immediately after treatment and at 1, 2, 3, and 12 months following AAV therapy.”
BackgroundBiophysical and structural insights into AAV genome ejection
Gliwa, K., Hull, J. A., Kansol, A., Zembruski, V., Lakshmanan, R., Mietzsch, M., Chipman, P. R., Bennett, A. D., & McKENNA, R. V. (2025) · Journal of Virology · doi:10.1128/jvi.00899-24 · Cited by 20
“These regions are termed variable based on differences between AAV serotypes (44), so the uniformity within AAV5 capsids at the different temperatures is expected.”
Self-citationTwinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies
Lerch, T. F., Xie, Q., Ongley, H. M., Hare, J. T., & Chapman, M. S. (2009) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309109000372 · Cited by 22
“The initial steps of structure determination have been repeated using the structures of AAV-4 (Govindasamy et al., 2006) and canine parvovirus (CPV; Tsao et al., 1991) as phasing models.”
MethodInfluentialCharacterization of Naturally-Occurring Humoral Immunity to AAV in Sheep
Tellez, J., Van Vliet, K., Tseng, Y.-S., Finn, J. D., Tschernia, N., Almeida-Porada, G., Arruda, V. R., Agbandje-McKenna, M., & Porada, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075142 · Cited by 18
Self-citationMultiparametric domain insertional profiling of adeno-associated virus VP1
Hoffmann, M. D., Zdechlik, A. C., He, Y., Nedrud, D. M., Aslanidi, G., Gordon, W. R., & Schmidt, D. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101143 · Cited by 18
Structural characterization of a bat Adeno-associated virus capsid
Mietzsch, M., Li, Y., Kurian, J. J., Smith, J. K., Chipman, P. R., McKENNA, R. V., Yang, L., & Agbandje‐McKenna, M. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107547 · Cited by 18
Self-citationA comprehensive study of AAV tropism across C57BL/6 mice, BALB/c mice, and crab-eating macaques
Fang, K., Yang, X., Liu, Y., Xia, J., Wu, R., Yang, F., Feng, C., Liu, X., Shi, L., Geng, G., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101434 · Cited by 18
N-glycomic profiling of capsid proteins from Adeno-Associated Virus serotypes
Xie, Y., & Butler, M. (2023) · Glycobiology · doi:10.1093/glycob/cwad074 · Cited by 18
“The majority of sequence variation falls within the surface-exposed regions of the capsid, referred to as hypervariable regions (HVRs) (Wu et al. 2000; Govindasamy et al. 2006; Lochrie et al. 2006; Nam et al. 2007; Mays et al. 2013).”
BackgroundStructural Study of Aavrh.10 Receptor and Antibody Interactions
Mietzsch, M., Yu, J. C., Hsi, J., Chipman, P. R., Broecker, F., Fuming, Z., Linhardt, R. J., Seeberger, P. H., Heilbronn, R., McKenna, R., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01249-21 · Cited by 16
Self-citationYe, X., Hu, Y., Qiu, H., & Li, N. (2024) · Protein Science · doi:10.1002/pro.5074 · Cited by 15
Hoad, M., Cross, E. M., Donnelly, C. M., Sarker, S., Roby, J. A., & Forwood, J. K. (2023) · Viruses · doi:10.3390/v15020315 · Cited by 17
Heffron, J., & Mayer, B. K. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.01674-20 · Cited by 15
Structural and antigenic characterization of the avian adeno-associated virus capsid
Hsi, J., Mietzsch, M., Chipman, P. R., Afione, S. A., Zeher, A., Huang, R. K., Chiorini, J. A., & McKENNA, R. V. (2023) · Journal of Virology · doi:10.1128/jvi.00780-23 · Cited by 14
“A total of nine variable regions (VRs) have been defined (28).”
BackgroundSelf-citationIntra- and Inter-Subunit Disulfide Bond Formation Is Nonessential in Adeno-Associated Viral Capsids
Pulicherla, N., Kota, P. B., Dokholyan, N. V., & Asokan, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032163 · Cited by 14
“In case of AAV capsids, the residues lining the two-fold (dimer) and five-fold (pentamer) interfaces are highly conserved between serotypes, while those creating the three-fold topology are more extensive and variable [6,7].”
BackgroundUnlocking precision gene therapy: harnessing AAV tropism with nanobody swapping at capsid hotspots
Hoffmann, M. D., Gallant, J. P., LeBeau, A. M., & Schmidt, D. (2024) · NAR Molecular Medicine · doi:10.1093/narmme/ugae008 · Cited by 17
“Despite high conservation in the overall structure and topology across serotypes, structural analyses have identified nine variable regions (VR1–9) on the capsid surface ( 8 ).”
Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2
Bennett, A. D., Hull, J. A., Jolinon, N., Tordo, J., Moss, K., Binns, E., Mietzsch, M., Hagemann, C., Linden, R. M., Serio, A., et al. (2021) · Journal of Structural Biology · doi:10.1016/j.jsb.2021.107795 · Cited by 14
Self-citationStructural characterization of an envelope-associated adeno-associated virus type 2 capsid
Hull, J. A., Mietzsch, M., Chipman, P. R., Strugatsky, D., & McKENNA, R. V. (2021) · Virology · doi:10.1016/j.virol.2021.09.010 · Cited by 14
Self-citationDeveloping New Vectors for Retinal Gene Therapy
Zin, E. A., Öztürk, B. E., Dalkara, D., & Byrne, L. C. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041291 · Cited by 14
Rationally engineered novel AAV capsids for intra-articular gene delivery
Li, W., Feng, S. L., Herrschaft, L., Samulski, R. J., & Li, C. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101211 · Cited by 12
Ikeda, T., Yamaguchi, Y., Oyama, H., Matsushita, A., Tsunaka, Y., Fukuhara, M., Torisu, T., & Uchiyama, S. (2024) · Viruses · doi:10.3390/v16040585 · Cited by 12
“Contrary to the conserved regions, rAAV also contains nine variable regions (VRs), which are structurally and sequentially diverse across serotypes [17].”
BackgroundTransduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9
Pasquale, G. D., Riveros, P. P., Tora, M. S., Sheikh, T., Son, A., Teos, L. Y., Grewe, B., Swaim, W. D., Afione, S. A., Zheng, C., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.10.006 · Cited by 12
Self-citationLi, L., Shen, T., Liu, S., Qi, J., & Zhao, Y. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1272786 · Cited by 18
Large, E. E., Silveria, M., Weerakoon, O., White, T., & Chapman, M. S. (2022) · Journal of Virology · doi:10.1128/jvi.01484-22 · Cited by 13
Hoad, M., Roby, J. A., & Forwood, J. K. (2021) · FEBS Letters · doi:10.1002/1873-3468.14209 · Cited by 10
Jiang, F., Zhang, C., Liu, W., Liu, F., Huang, H., Tan, Y. F., & Qin, B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1301915 · Cited by 9
Cryo-EM structure of adeno-associated virus 4 at 2.2 Å resolution
Zane, G. M., Silveria, M., Meyer, N., White, T., Duan, R., Zou, X., & Chapman, M. S. (2023) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798322012190 · Cited by 10
The amazing AAV capsids: Into the structure-verse
Hsi, J., Mietzsch, M., & McKENNA, R. V. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101629 · Cited by 12
“66 Using secondary structure matching, the VP3 models of AAV2 and AAV4 were superposed, resulting in an overall C α RMSD of 1.0 Å. 66 While the capsid core showed nearly exact overlap of both structures’ coordinates, significant positional differences were observed in the surface loops.”
InfluentialSelf-citationWu, R., Ozkan, A., Bennett, A. D., Agbandje‐McKenna, M., & Sitharam, M. (2012) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2382936.2383061 · Cited by 8
“The potential energy basins of an interface assembly system are centered around the configurations in the zero-dimensional active constraint regions of the configuration space atlas.”
BackgroundSelf-citationStructural basis for nuclear import of bat adeno-associated virus capsid protein
Hoad, M., Roby, J. A., & Forwood, J. K. (2024) · Journal of General Virology · doi:10.1099/jgv.0.001960 · Cited by 8
“The capsid is formed with a total of 60 VP subunits assembled through interactions which allow for the formation of pores within the capsid connecting the external milieu to the inside of the virion shell [53].”
BackgroundThe Structural, Biophysical, and Antigenic Characterization of the Goose Parvovirus Capsid
Jabbari, K., Mietzsch, M., Hsi, J., Chipman, P. R., Qiu, J., & McKENNA, R. V. (2025) · Microorganisms · doi:10.3390/microorganisms13010080 · Cited by 8
“In addition, segments of these loops have been defined and are known as variable regions (VRs), which are characterized by their sequence and structural diversity among different parvovirus genera [23].”
Self-citationModeling Autonomous Supramolecular Assembly
Sitharam, M. (2013) · Natural computing series · doi:10.1007/978-3-642-40193-0_9 · Cited by 7
Rana, J., Marsic, D., Zou, C., Muñoz-Melero, M., Li, X., Kondratov, O., Li, N., de Jong, Y. P., Zolotukhin, S., & Biswas, M. (2023) · Human Gene Therapy · doi:10.1089/hum.2022.176 · Cited by 9
“76,77 Other directed evolution studies have implied that VR-IV and VR-VIII are more likely to dictate host cell interactions that determine evolutionary pressure.”
A Penetrable AAV2 Capsid Variant for Efficient Intravitreal Gene Delivery to the Retina
He, X., Fu, Y., Xu, Y., Ma, L., Chai, P., Shi, H., Yao, Y., Ge, S., Jia, R., Wen, X., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.1.6 · Cited by 7
“27 Research has introduced muscle-targeting peptides into positions 587 or 588 of the AAV2 capsid, resulting in both variants exhibiting reduced infectivity in non-muscle cell lines and undifferentiated myoblasts but showing enhanced infectivity in differentiated myotubes.”
Protein Carrier Adeno-Associated Virus
Hoffmann, M. D., Sorensen, R. J., Extross, A., He, Y., & Schmidt, D. (2025) · ACS Nano · doi:10.1021/acsnano.5c01498 · Cited by 6
Ye, X., Hu, M., Hu, Y., Qiu, H., & Li, N. (2025) · Gene Therapy · doi:10.1038/s41434-025-00539-4 · Cited by 7
“These structures have been primarily determined by X-ray crystallography [5 – 7] and cryogenic electron microscopy [8 – 11].”
Characteristics, Recombination Methods, and Applications Progresses of Split-Cas9 System
Liu, Z., Huang, L., Deng, H., Chen, Y., & Xiao, H. (2023) · Human Gene Therapy · doi:10.1089/hum.2022.223 · Cited by 5
“26 AAV carries CRISPR system and enters cells mainly through endocytosis (Fig.”
Egorova, T. V., Piskunov, A. A., & Poteryaev, D. A. (2024) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2024-24-2-123-139 · Cited by 5
Viral Vector Technologies and Strategies: Improving on Nature
Croze, R. H., Kotterman, M. A., Burns, C. H., Schmitt, C. E., Quezada, M., Schaffer, D. V., Kirn, D. H., & Francis, P. J. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000361 · Cited by 5
I Am Here: It Took a Global Village
Agbandje‐McKenna, M. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-091919-104940 · Cited by 5
Self-citationLin, X., Chen, L., Jia, K., Li, S., Li, Q., Yi, J., & Xing, J. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s566642 · Cited by 6
Milagros, S., de Erenchun, P. R.-R., Guembe, M., Carte, B., Méndez, M., Uribarri, A., & Aldabe, R. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00430-7 · Cited by 4
“Subsequent research revealed specific glycans for other serotypes, such as sialic acid moieties for AAV5, -1, -6, and -4, and galactose for AAV9 [12–15].”
BackgroundResearch Status and Applications of Adeno‐Associated Virus
Xia, K., Liu, S., Wu, Z., & Jiang, J. (2025) · ChemBioChem · doi:10.1002/cbic.202400856 · Cited by 4
Interplay between Furin and Sialoglycans in Modulating Adeno-Associated Viral Cell Entry
Smith, T. J., Fusco, R. M., Elmore, Z. C., & Asokan, A. (2023) · Journal of Virology · doi:10.1128/jvi.00093-23 · Cited by 4
Adeno-associated Virus as a Mammalian DNA Vector
Salganik, M., Hirsch, M. L., & Samulski, R. J. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch37 · Cited by 5
Yu, D. L., van Lieshout, L. P., Stevens, B. A. Y., Near, K. J., Stodola, J. K., Stinson, K. J., Slavić, Ð., & Wootton, S. K. (2023) · Viruses · doi:10.3390/v16010057 · Cited by 5
“In addition, the arginine-to-glycine change occurs in a variable region known to play a role in virus neutralization, heparin binding, and cell transduction [33].”
BackgroundStructural Characterization of Human Bufavirus 1: Receptor Binding and Endosomal pH-Induced Changes
Gulkis, M., Luo, M., Chipman, P. R., Mietzsch, M., Söderlund‐Venermo, M., Bennett, A. D., & McKENNA, R. V. (2024) · Viruses · doi:10.3390/v16081258 · Cited by 3
“These loops create structural differences between viruses, which have been previously categorized into variable regions (VRs) [23,37].”
BackgroundSelf-citationGene Delivery Systems: Tailoring Vectors to Reach Specific Tissues
Alméciga-Díaz, C. J., Cuaspa, R., & Luis, A. (2011) · InTech eBooks · doi:10.5772/20074 · Cited by 3
The Cold Case Files of rAAV Capsid Influence on Transduction: New Leads
Powell, S. (2025) · Viruses · doi:10.3390/v17111476 · Cited by 2
“The capsid crystal structures of several AAV serotypes have been resolved, but they only show VP3 subunits ordered [6–8] which is similar to other parvoviruses [1,9].”
Parambathu, A. V., Kumar, V., Khanal, O., & Lenhoff, A. M. (2025) · Molecular Therapy Advances · doi:10.1016/j.omta.2025.201656 · Cited by 2
孔令芸, Xin, C., Cheng, M., Ma, S., Zheng, Z., Chen, J., & Zhou, X. (2026) · Eye Discovery · doi:10.1016/j.edisc.2026.100040 · Cited by 2
Noriega, H. A., Qizhao, W., Yu, D., & Wang, X. S. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1559461 · Cited by 2
Hsi, J., Mietzsch, M., Patney, M., Chen, S., Sawh-Gopal, A., Chipman, P. R., & McKENNA, R. V. (2025) · Journal of Virology · doi:10.1128/jvi.00110-25 · Cited by 2
“The apices of these loops display the most differences and are defined as variable regions (VRs), if two or more amino acids have Cα positions that differ greater than 2 Å when their VPs are superposed (33, 34).”
Self-citationSequence Conservation, Radial Distance and Packing Density in Spherical Viral Capsids
Chang, C.-M., Huang, Y.-W., Lee, C.-W., Huang, T.-T., Chung-Shiuan, S., & Hwang, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132234 · Cited by 2
PEP-TP56 enhances AAV transduction in a serotype-independent manner
Olarewaju, O., Held, F., Schön, C., Maier, U., & du Plessis, F. (2026) · Heliyon · doi:10.1016/j.heliyon.2025.e44471 · Cited by 1
Nelson, A. T., Smith, A., Curley, C. T., Kelly, B., Ganesh, A. N., Peterson, D., Fabyanic, E. B., Kostuk, E. W., Weber, T., & Engel, E. A. (2026) · Human Gene Therapy · doi:10.1177/10430342251411044 · Cited by 1
“14,15 For example, mutagenesis of the AAV9 capsid at positions G267, N270, and N272 have been shown to reduce AAV9 liver transduction, 16 – 18 although the underlying mechanism has not been elucidated.”
Structural and Functional Characterization of Porcine Adeno-Associated Viruses
Nelson, A. R., Mietzsch, M., Hsi, J., Eby, J., Chipman, P. R., & McKENNA, R. V. (2025) · Viruses · doi:10.3390/v17091260 · Cited by 1
“Loops connecting these β -strands form the capsid surface and vary among AAVs, which have been designated as variable regions (VRs): VR I–IX [11,12].”
Self-citationStrategies for improving adeno-associated viral infection of airway epithelial cells
Dickey, D. D. (2012) · doi:10.17077/etd.m1aiqczb
“to form novel viral-cell interactions that would be optimal to transduce particular tissues, despite advances in understanding AAV structure and function (29, 30, 148, 149).”
BackgroundUNDERSTANDING THE SOLUTION-PHASE BIOPHYSICS AND CONFORMATIONAL DYNAMICS OF VIRUS CAPSIDS
Rayaprolu, V. (2013) · Montana State University ScholarWorks (Montana State University)
Yu, D. L. (2015) · The Atrium (University of Guelph)
Serotype 8 Capsid of Adeno-Associated Virus Mapping a Neutralizing Epitope onto the
Agbandje‐McKenna, M., Baker, T. S., Kleinschmidt, J. A., Naumer, M., Olson, N. H., Ng, R., Gurda, L., Raupp, C., & Popa-Wagner, R. (2012)
Self-citationX-ray Crystallography of Virus Capsids
Govindasamy, L., Agbandje‐McKenna, M., & McKENNA, R. V. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732239-00100
Self-citationBiology of AAV Vectors in the Central Nervous System
Murlidharan, G. (2016) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/cr64-be62
Intracellular fate of AAV particles in human Dendritic Cell and impact on Gene Transfer
Rossi, A. (2016) · theses.fr (ABES) · doi:10.70675/4518d4eazdbd8z4f46z96e2zf87942913c70
Warischalk, J. K. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/dqdt-1s58 · Cited by 1
Chand, A. (2012) · Mspace (University of Manitoba)
DETERMINANTS OF AAV TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER
Albright, B. H. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/vnpr-wx33
Adeno-associated virus-mediated gene therapy in central nervous system genetic disorders
Casy, W., Ling, Q., Shaffo, F. C., Sinnett, S. E., & Gray, S. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00010-6 · Cited by 1
Evans, D. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1158992.619263
Silveria, M. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/94095
Kwiatek, M., Michalski, A., Abramowicz, K., Rutyna, P., Wasiak, M., Reichert, M., & Lisowski, L. (2023) · Lekarz Wojskowy · doi:10.53301/lw/156374
Adeno-associated virus-mediated gene therapy in central nervous system genetic disorders
Ling, Q., Boitnott, A., Garza, I. T., Casy, W., Shaffo, F. C., Sinnett, S. E., & Gray, S. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00007-8
Di-methylation of a specific arginine in AAV5 capsid proteins
Levine, J., & Lippincott, J. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.103891
Milagros, S., de Erenchun, P. R.-R., Guembe, M., Carte, B., Méndez, M., Uribarri, A., & Aldabe, R. (2024) · Figshare · doi:10.6084/m9.figshare.25824759
Exploration of genes and identification of evolutionary evidence in adeno-associated viruses
Lee, C., Min, J., Lim, S., Park, A., Kwak, S., Hwang, S., Park, S., Jang, Y., Cha, S.-Y., Cho, S.-G., et al. (2026) · The Journal of Microbiology · doi:10.71150/jm.2511016
“Earlier research identified specific variable regions (VRs) in VP1, VP2, and VP3 by comparing amino acid sequences among different serotypes (Govindasamy et al., 2006; Nam et al., 2007).”
Glicosilación del virus adenoasociado (AAV) para mejorar infectividad celular
Bravo, I. O. (2025) · Academica-e (Universidad Pública de Navarra)
Metadata
- Authors
- Govindasamy, L., Padron, E., McKenna, R., Muzyczka, N., Kaludov, N., Chiorini, J. A., & Agbandje-McKenna, M.
- Affiliations
- Department of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida 32610
- University of Florida (US)
- National Institutes of Health (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-12
- Volume
- 80
- Issue
- 23
- Pages
- 11556-11570
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC1642620
- OpenAlex
- W2149678280
- Cited by
- 205
- References
- 71
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 14 · 2023: 18 · 2022: 11 · 2021: 17 · 2020: 13 · 2019: 8 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 9 · 2014: 10 · 2013: 13 · 2012: 16
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01-HL51811, P01HL051811)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Infectious Diseases › Parvovirus B19 Infection Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- capsid protein, AAV2, heparin binding, receptor recognition, transduction, gene delivery vectors
- MeSH terms
- Dependovirus, Binding Sites, Capsid, Phenotype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.